4.8 Article

Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 4, Pages 1298-1312

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI43414

Keywords

-

Funding

  1. Pediatric Oncology Research Fellowship
  2. Charles Eliot Ware Memorial Fellowship
  3. National Cancer Institute [CA093900]
  4. Department of Defense
  5. Prostate Cancer Foundation
  6. American Cancer Society
  7. NIH [P50 CA69568]
  8. Cancer Center [P30 CA46592]

Ask authors/readers for more resources

HSC homing, quiescence, and self-renewal depend on the bone marrow HSC niche. A large proportion of solid tumor metastases are bone metastases, known to usurp HSC homing pathways to establish footholds in the bone marrow. However, it is not clear whether tumors target the HSC niche during metastasis. Here we have shown in a mouse model of metastasis that human prostate cancer (PCa) cells directly compete with HSCs for occupancy of the mouse HSC niche. Importantly, increasing the niche size promoted metastasis, whereas decreasing the niche size compromised dissemination. Furthermore, disseminated PCa cells could be mobilized out of the niche and back into the circulation using HSC mobilization protocols. Finally, once in the niche, tumor cells reduced HSC numbers by driving their terminal differentiation. These data provide what we believe to be the first evidence that the HSC niche serves as a direct target for PCa during dissemination and plays a central role in bone metastases. Our work may lead to better understanding of the molecular events involved in bone metastases and new therapeutic avenues for an incurable disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available